Mason Street Advisors’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-180,561
Closed -$12.3M 316
2020
Q4
$12.3M Sell
180,561
-3,249
-2% -$211K 0.21% 80
2020
Q3
$10.7M Sell
183,810
-2,796
-1% -$174K 0.21% 83
2020
Q2
$12.1M Buy
186,606
+988
+0.5% +$62.2K 0.24% 72
2020
Q1
$11M Hold
185,618
0.25% 73
2019
Q4
$13.8M Buy
185,618
+339
+0.2% +$23.8K 0.26% 69
2019
Q3
$11.7M Buy
185,279
+6
+0% +$356 0.24% 73
2019
Q2
$10.1M Buy
185,273
+227
+0.1% +$12.2K 0.21% 82
2019
Q1
$9.98M Buy
185,046
+2,724
+1% +$168K 0.2% 89
2018
Q4
$11.9M Buy
182,322
+39,204
+27% +$2.93M 0.29% 65
2018
Q3
$11.3M Buy
143,118
+480
+0.3% +$34.3K 0.23% 77
2018
Q2
$9.18M Buy
142,638
+1,316
+0.9% +$86.7K 0.2% 80
2018
Q1
$8.79M Buy
141,322
+220
+0.2% +$15.8K 0.2% 88
2017
Q4
$10.2M Sell
141,102
-16
-0% -$1.16K 0.23% 79
2017
Q3
$11.5M Sell
141,118
-280
-0.2% -$22.1K 0.27% 67
2017
Q2
$11.4M Sell
141,398
-346
-0.2% -$27.3K 0.28% 59
2017
Q1
$11.1M Sell
141,744
-4,140
-3% -$331K 0.29% 62
2016
Q4
$11.5M Buy
145,884
+1,647
+1% +$133K 0.31% 57
2016
Q3
$12.8M Sell
144,237
-427
-0.3% -$40.3K 0.37% 48
2016
Q2
$13.8M Sell
144,664
-1,657
-1% -$165K 0.4% 46
2016
Q1
$15.2M Buy
146,321
+1,662
+1% +$162K 0.46% 36
2015
Q4
$14.1M Buy
144,659
+460
+0.3% +$45.1K 0.44% 40
2015
Q3
$13.9M Sell
144,199
-1,090
-0.8% -$115K 0.47% 35
2015
Q2
$15.2M Buy
145,289
+374
+0.3% +$38.2K 0.47% 37
2015
Q1
$15M Sell
144,915
-422,797
-74% -$42.8M 0.45% 38
2014
Q4
$54.7M Sell
567,712
-27,784
-5% -$2.45M 0.38% 35
2014
Q3
$47.4M Sell
595,496
-19,045
-3% -$1.5M 0.37% 38
2014
Q2
$46.3M Buy
614,541
+23,986
+4% +$1.81M 0.36% 42
2014
Q1
$44.2M Sell
590,555
-37,980
-6% -$2.68M 0.36% 42
2013
Q4
$45M Sell
628,535
-128,215
-17% -$8.24M 0.37% 42
2013
Q3
$42.9M Sell
756,750
-318,072
-30% -$19M 0.49% 27
2013
Q2
$61.5M Buy
+1,074,822
New +$62.3M 0.68% 20

Other funds holding CVS

Mason Street Advisors's CVS Position: Q1 2021 in Review

Mason Street Advisors sold out of CVS Health (CVS) in Q1 2021, closing a stake of 180,561 shares — an estimated $12.3M sold.

Mason Street Advisors first reported a position in CVS in Q2 2013 and held it in 31 quarters. The position peaked at $61.5M in Q2 2013. 2,032 funds tracked by Wall St. Rank hold CVS as of Q1 2021.

  • Mason Street Advisors reported no remaining CVS Health position as of Q1 2021 after selling out during the quarter.
  • Mason Street Advisors sold 180,561 CVS Health shares in Q1 2021, an estimated $12.3M.
  • Mason Street Advisors first reported a position in CVS Health in Q2 2013 and held it in 31 quarters.
  • Mason Street Advisors's CVS Health position peaked at $61.5M in Q2 2013.
  • 2,032 funds tracked by Wall St. Rank held CVS Health as of Q1 2021.

Based on Mason Street Advisors's 13F filing for Q1 2021, filed 14 May 2021.